JTK-853 is a novel, non-nucleoside Hepatitis C Virus ( HCV ) polymerase inhibitor which shows effective antiviral activity in HCV replicon cells with EC 50 s of 0.38 and 0.035 µM in genotype 1a H77 and 1b Con1 strains, respectively.
Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HCV
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.